GlucoTrack (GCTK) 10-Q19 Aug 142014 Q2 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
Document and Entity Information	Jun. 30, 2014	Aug. 19, 2014
Document and Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Jun-14	'
Entity Registrant Name	'Integrity Applications, Inc.	'
Entity Central Index Key	'0001506983	'
Current Fiscal Year End Date	'--12-31	'
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	5,304,072

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Jun. 30, 2014	Dec. 31, 2013
Current Assets	'	'
Cash and cash equivalents	$589,736	$2,385,911
Other current assets	118,661	93,052
Total current assets	708,397	2,478,963
Property and Equipment, Net	139,753	107,209
Funds in Respect of Employee Rights Upon Retirement	171,664	170,033
Total assets	1,019,814	2,756,205
Current Liabilities	'	'
Accounts payable	169,146	49,787
Other current liabilities	347,959	261,120
Total current liabilities	517,105	310,907
Long-Term Liabilities	'	'
Long-Term Loans from Stockholders	698,375	693,092
Liability for Employee Rights Upon Retirement	238,340	236,074
Warrants with Down-Round Protection (See Note 2B)	1,923,000	8,216,705
Total long-term liabilities	2,859,715	9,145,871
Total liabilities	3,376,820	9,456,778
Commitments and Contingent Liabilities	'	'
Temporary Equity	'	'
Convertible Preferred Stock of $ 0.001 par value ("Preferred Stock"): 10,000,000 shares authorized as of June 30, 2014 and December 31, 2013; issued and outstanding 7,407 shares as of June 30, 2014 and 7,417 shares as of December 31, 2013	4,356,657	4,362,545
Stockholders' Equity (Deficit)	'	'
Common Stock of $ 0.001 par value ("Common Stock"): 40,000,000 shares authorized as of June 30, 2014 and December 31, 2013; issued and outstanding 5,304,072 shares and 5,301,693 shares as of June 30, 2014 and December 31, 2013, respectively	5,305	5,302
Additional paid in capital	14,557,807	14,532,068
Accumulated other comprehensive income	36,669	52,702
Deficit accumulated during the development stage	-21,313,444	-25,653,190
Total stockholders' deficit	-6,713,663	-11,063,118
Total liabilities, temporary equity and stockholders' deficit	$1,019,814	$2,756,205

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Temporary Equity	'	'
Convertible Preferred Stock, par value per share	$0.00	$0.00
Convertible Preferred Stock, shares authorized	10,000,000	10,000,000
Convertible Preferred Stock, shares issued	7,407	7,417
Convertible Preferred Stock, shares outstanding	7,407	7,417
Common stock, par value per share	$0.00	$0.00
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	5,304,072	5,301,693
Common stock, shares outstanding	5,304,072	5,301,693

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (USD $)	3 Months Ended				6 Months Ended				153 Months Ended
	Jun. 30, 2014		Jun. 30, 2013		Jun. 30, 2014		Jun. 30, 2013		Jun. 30, 2014
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) [Abstract]	'		'		'		'		'
Research and development expenses, net	$454,789		$461,303		$905,873		$965,548		$13,369,031
Selling, marketing and general and administrative expenses	427,537		370,491		863,639		554,070		4,919,421
Other income	'		'		'		'		-912
Operating loss	882,326		831,794		1,769,512		1,519,618		18,287,540
Financing (income) expenses, net	-6,144,254	[1]	-255,197	[1]	-6,294,521	[1]	400,574	[1]	2,274,130	[1]
Income (loss) for the period	5,261,928		-576,597		4,525,009		-1,920,192		-20,561,670
Other comprehensive (income) loss:	'		'		'		'		'
Foreign currency translation adjustment	-16,905		12,447		-16,033		18,800		36,669
Comprehensive income (loss) for the period	$5,278,833		($589,044)		$4,541,042		($1,938,992)		($20,598,339)
Income (loss) per share (Basic) (Note 3)	$0.79		($0.13)		$0.66		($0.38)		'
Income (loss) per share (Diluted) (Note 3)	$0.78		($0.13)		$0.65		($0.38)		'
Common shares used in computing Basic income (loss) per share (Note 3)	5,304,072		5,297,693		5,303,529		5,363,302		'
Common shares used in computing Diluted income (loss) per share (Note 3)	5,336,019	[2]	5,297,693	[2]	5,361,570	[2]	5,363,302	[2]	'

[1]	Includes ($6,293,705) relating to changes in the fair value estimate of the warrants with down-round protection and $390,928 of issuance costs allocated to the warrants with down-round protection, for the six month period ended June 30, 2014 and June 30, 2013, respectively and ($6,147,835) and ($220,132) relating to changes in the fair value estimate of the warrants with down-round protection, for the three month period ended June 30, 2014 and June 30, 2013, respectively.
[2]	In applying the treasury method, the average market price of Common Stock was based on management estimate (see Note 2B, above).

CONSOLIDATED_STATEMENTS_OF_OPE1

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Parenthetical) (USD $)	6 Months Ended
	Jun. 30, 2013
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) [Abstract]	'
Change in the fair value of warrants issued with round down protection	($68,643)
Issuance costs allocated to warrants with down-round protection	$390,928

STATEMENTS_OF_CHANGES_IN_STOCK

STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (USD $)	Total	Common Stock [Member]	Additional paid in capital [Member]	Accumulated other comprehensive income (loss) [Member]	Receivable in respect of stock issuance [Member]	Deficit accumulated during development stage [Member]
Balance at Sep. 29, 2001	'	'	'	'	'	'
Balance, shares at Sep. 29, 2001	'	'	'	'	'	'
2,136,307 shares of Common Stock of par value $0.001 per share issued for cash	40,442	2,136	38,306	'	'	'
2,136,307 shares of Common Stock of par value $0.001 per share issued for cash, shares	'	2,136,307	'	'	'	'
Income (Loss) for the period/year	-63,293	'	'	'	'	-63,293
Other comprehensive income (loss)	-5	'	'	-5	'	'
Balance at Dec. 31, 2002	-22,856	2,136	38,306	-5	'	-63,293
Balance, shares at Dec. 31, 2002	'	2,136,307	'	'	'	'
Income (Loss) for the period/year	-350,290	'	'	'	'	-350,290
Other comprehensive income (loss)	-15,035	'	'	-15,035	'	'
Balance at Dec. 31, 2003	-388,181	2,136	38,306	-15,040	'	-413,583
Balance, shares at Dec. 31, 2003	'	2,136,307	'	'	'	'
Income (Loss) for the period/year	-288,233	'	'	'	'	-288,233
Other comprehensive income (loss)	-15,069	'	'	-15,069	'	'
Issuance of 42,727 shares of Common Stock for cash of $1.76 per share on March 16, 2004	75,000	43	74,957	'	'	'
Issuance of 42,727 shares of Common Stock for cash of $1.76 per share on March 16, 2004, shares	'	42,727	'	'	'	'
Issuance of 72,773 shares of Common Stock for cash of $ 1.72 per share on November 25, 2004	128,856	73	128,783	'	'	'
Issuance of 72,773 shares of Common Stock for cash of $ 1.72 per share on November 25, 2004, shares	'	72,773	'	'	'	'
Balance at Dec. 31, 2004	-487,627	2,252	242,046	-30,109	'	-701,816
Balance, shares at Dec. 31, 2004	'	2,251,807	'	'	'	'
Income (Loss) for the period/year	-1,055,594	'	'	'	'	-1,055,594
Other comprehensive income (loss)	8,542	'	'	8,542	'	'
Issuance of 218,281 shares of Common Stock for cash of $ 1.72 per share on January 14, 2005	375,000	218	374,782	'	'	'
Issuance of 218,281 shares of Common Stock for cash of $ 1.72 per share on January 14, 2005, shares	'	218,281	'	'	'	'
Issuance of 291,051 shares of Common Stock for cash of $ 1.72 per share on April 5, 2005	500,000	291	499,709	'	'	'
Issuance of 291,051 shares of Common Stock for cash of $ 1.72 per share on April 5, 2005, shares	'	291,051	'	'	'	'
Issuance of 59,389 shares of Common Stock for cash of $ 3.37 per share on May 31, 2005	200,000	60	199,940	'	'	'
Issuance of 59,389 shares of Common Stock for cash of $ 3.37 per share on May 31, 2005, shares	'	59,389	'	'	'	'
Stock-based compensation	189,616	52	189,564	'	'	'
Stock-based compensation, shares	'	52,147	'	'	'	'
Balance at Dec. 31, 2005	-270,063	2,873	1,506,041	-21,567	'	-1,757,410
Balance, shares at Dec. 31, 2005	'	2,872,675	'	'	'	'
Income (Loss) for the period/year	-1,282,842	'	'	'	'	-1,282,842
Other comprehensive income (loss)	-57,127	'	'	-57,127	'	'
Issuance of 87,315 shares of Common Stock for cash of $ 1.47 per share on January 26, 2006	128,205	87	128,118	'	'	'
Issuance of 87,315 shares of Common Stock for cash of $ 1.47 per share on January 26, 2006	'	87,315	'	'	'	'
Issuance of 1,899 shares of Common Stock for cash of $ 3.63 per share on March 31, 2006	6,890	2	6,888	'	'	'
Issuance of 1,899 shares of Common Stock for cash of $ 3.63 per share on March 31, 2006	'	1,899	'	'	'	'
Issuance of 13,786 shares of Common Stock for cash of $ 3.63 per share on June 16, 2006	50,000	14	49,986	'	'	'
Issuance of 13,786 shares of Common Stock for cash of $ 3.63 per share on June 16, 2006, shares	'	13,786	'	'	'	'
Issuance of 14,113 shares of Common Stock for cash of $ 3.63 per share on June 30, 2006	51,180	14	51,166	'	'	'
Issuance of 14,113 shares of Common Stock for cash of $ 3.63 per share on June 30, 2006, shares	'	14,113	'	'	'	'
Issuance of 51,207 shares of Common Stock for cash of $ 3.91 per share on August 15, 2006	200,000	51	199,949	'	'	'
Issuance of 51,207 shares of Common Stock for cash of $ 3.91 per share on August 15, 2006, shares	'	51,207	'	'	'	'
Issuance of 301,948 shares of Common Stock for cash of $ 4.31 per share on October 5, 2006	1,300,000	302	1,299,698	'	'	'
Issuance of 301,948 shares of Common Stock for cash of $ 4.31 per share on October 5, 2006, shares	'	301,948	'	'	'	'
Issuance of 348,402 shares of Common Stock for cash of $ 4.31 per share on December 14, 2006	1,372,495	349	1,372,146	'	'	'
Issuance of 348,402 shares of Common Stock for cash of $ 4.31 per share on December 14, 2006, shares	'	348,402	'	'	'	'
Stock-based compensation	277,497	63	277,434	'	'	'
Stock-based compensation, shares	'	63,395	'	'	'	'
Balance at Dec. 31, 2006	1,776,235	3,755	4,891,426	-78,694	'	-3,040,252
Balance, shares at Dec. 31, 2006	'	3,754,740	'	'	'	'
Income (Loss) for the period/year	-1,593,205	'	'	'	'	-1,593,205
Other comprehensive income (loss)	84,528	'	'	84,528	'	'
Stock-based compensation	274,659	29	274,630	'	'	'
Stock-based compensation, shares	'	28,707	'	'	'	'
Balance at Dec. 31, 2007	542,217	3,784	5,166,056	5,834	'	-4,633,457
Balance, shares at Dec. 31, 2007	'	3,783,447	'	'	'	'
Income (Loss) for the period/year	-1,528,981	'	'	'	'	-1,528,981
Other comprehensive income (loss)	110,134	'	'	110,134	'	'
Issuance of 61,989 shares of Common Stock for cash of $ 5.52 per share on September 27, 2008	342,000	62	341,938	'	'	'
Issuance of 61,989 shares of Common Stock for cash of $ 5.52 per share on September 27, 2008, shares	'	61,989	'	'	'	'
Issuance of 104,220 shares of Common Stock for cash of $ 5.52 per share on October 7, 2008	500,000	104	574,896	'	-75,000	'
Issuance of 104,220 shares of Common Stock for cash of $ 5.52 per share on October 7, 2008, shares	'	104,220	'	'	'	'
Stock-based compensation	84,380	'	84,380	'	'	'
Balance at Dec. 31, 2008	49,750	3,950	6,167,270	115,968	-75,000	-6,162,438
Balance, shares at Dec. 31, 2008	'	3,949,656	'	'	'	'
Income (Loss) for the period/year	-1,202,296	'	'	'	'	-1,202,296
Other comprehensive income (loss)	-13,367	'	'	-13,367	'	'
Issuance of 50,342 shares of Common Stock for cash of $6.02 per share in January 2009	303,000	50	302,950	'	'	'
Issuance of 50,342 shares of Common Stock for cash of $6.02 per share in January 2009, shares	'	50,342	'	'	'	'
Repayment of receivable in respect of stock issuance	75,000	'	'	'	75,000	'
Stock-based compensation	12,171	'	12,171	'	'	'
Balance at Dec. 31, 2009	-775,742	4,000	6,482,391	102,601	'	-7,364,734
Balance, shares at Dec. 31, 2009	'	3,999,998	'	'	'	'
Income (Loss) for the period/year	-2,788,446	'	'	'	'	-2,788,446
Other comprehensive income (loss)	-119,019	'	'	-119,019	'	'
Issuance of 530,600 shares of Common Stock for cash of $6.25 per share in December 2010, net of related expenses	2,357,032	531	2,356,501	'	'	'
Issuance of 530,600 shares of Common Stock for cash of $6.25 per share in December 2010, net of related expenses, shares	'	530,600	'	'	'	'
Stock-based interest compensation to convertible notes holders	1,214,943	194	1,214,749	'	'	'
Stock-based interest compensation to convertible notes holders, shares	'	194,391	'	'	'	'
Conversion of convertible notes	694,796	120	694,676	'	'	'
Conversion of convertible notes, shares	'	119,586	'	'	'	'
Stock-based compensation	14,575	'	14,575	'	'	'
Balance at Dec. 31, 2010	598,139	4,845	10,762,892	-16,418	'	-10,153,180
Balance, shares at Dec. 31, 2010	'	4,844,575	'	'	'	'
Income (Loss) for the period/year	-2,364,339	'	'	'	'	-2,364,339
Other comprehensive income (loss)	39,052	'	'	39,052	'	'
Issuance of 16,320 shares of Common Stock for cash of $ 6.25 per share on January 31, 2011, net of related expenses	83,180	16	83,164	'	'	'
Issuance of 16,320 shares of Common Stock for cash of $ 6.25 per share on January 31, 2011, net of related expenses, shares	'	16,320	'	'	'	'
Issuance of 90,768 shares of Common Stock for cash of $ 6.25 per share on March 31, 2011, net of related expenses	479,901	91	479,810	'	'	'
Issuance of 90,768 shares of Common Stock for cash of $ 6.25 per share on March 31, 2011, net of related expenses, shares	'	90,768	'	'	'	'
Issuance of 40,000 shares of Common Stock for cash of $ 6.25 per share on April 29, 2011, net of related expenses	191,722	40	191,682	'	'	'
Issuance of 40,000 shares of Common Stock for cash of $ 6.25 per share on April 29, 2011, net of related expenses, shares	'	40,000	'	'	'	'
Issuance of 34,200 shares of Common Stock for cash of $ 6.25 per share on May 31, 2011, net of related expenses	180,026	34	179,992	'	'	'
Issuance of 34,200 shares of Common Stock for cash of $ 6.25 per share on May 31, 2011, net of related expenses, shares	'	34,200	'	'	'	'
Issuance of 269,680 shares of Common Stock for cash of $ 6.25 per share on July 29, 2011, net of related expenses	1,466,385	270	1,466,115	'	'	'
Issuance of 269,680 shares of Common Stock for cash of $ 6.25 per share on July 29, 2011, net of related expenses, shares	'	269,680	'	'	'	'
Fair value of warrants with down-round protection issued in connection with Common Stock issuances	-83,899	'	-83,899	'	'	'
Stock-based compensation	378,072	'	378,072	'	'	'
Balance at Dec. 31, 2011	968,239	5,296	13,457,828	22,634	'	-12,517,519
Balance, shares at Dec. 31, 2011	'	5,295,543	'	'	'	'
Income (Loss) for the period/year	-2,772,307	'	'	'	'	-2,772,307
Other comprehensive income (loss)	-13,709	'	'	-13,709	'	'
Issuance of 165,057 shares of Common Stock for cash of $ 7.00 per share on November 19, 2012, net of related expenses	917,179	165	917,014	'	'	'
Issuance of 165,057 shares of Common Stock for cash of $ 7.00 per share on November 19, 2012, net of related expenses, shares	'	165,057	'	'	'	'
Warrants classified to equity due to the expiration of the down-round protection period/Warrants issued as consideration for placement services	48,007	'	48,007	'	'	'
Stock-based compensation	349,522	'	349,522	'	'	'
Balance at Dec. 31, 2012	-503,069	5,461	14,772,371	8,925	'	-15,289,826
Balance, shares at Dec. 31, 2012	'	5,460,600	'	'	'	'
Income (Loss) for the period/year	-9,796,853	'	'	'	'	-9,796,853
Other comprehensive income (loss)	43,777	'	'	43,777	'	'
Amount classified out of stockholders equity and presented as liability and temporary equity with respect to Common Stock replaced with units comprised of convertible Preferred Stock and warrants	-1,140,349	-163	-1,140,186	'	'	'
Amount classified out of stockholders equity and presented as liability and temporary equity with respect to Common Stock replaced with units comprised of convertible Preferred Stock and warrants, shares	'	-162,907	'	'	'	'
Conversion of Preferred Stock	23,200	4	23,196	'	'	'
Conversion of Preferred Stock, shares	'	4,000	'	'	'	'
Stock dividend to certain Common Stock holders	'	'	278,263	'	'	-278,263
Stock dividend to certain Common Stock holders, shares	'	'	'	'	'	'
Warrants classified to equity due to the expiration of the down-round protection period/Warrants issued as consideration for placement services	562,805	'	562,805	'	'	'
Dividend on convertible Preferred Stock	-288,248	'	'	'	'	-288,248
Stock-based compensation	35,619	'	35,619	'	'	'
Balance at Dec. 31, 2013	-11,063,118	5,302	14,532,068	52,702	'	-25,653,190
Balance, shares at Dec. 31, 2013	5,301,693	5,301,693	'	'	'	'
Income (Loss) for the period/year	4,525,009	'	'	'	'	4,525,009
Other comprehensive income (loss)	-16,033	'	'	-16,033	'	'
Conversion of Preferred Stock	5,888	2	5,886	'	'	'
Conversion of Preferred Stock, shares	'	1,725	'	'	'	'
Stock dividend to certain Common Stock holders	'	1	-1	'	'	'
Stock dividend to certain Common Stock holders, shares	'	654	'	'	'	'
Dividend on convertible Preferred Stock	-185,263	'	'	'	'	-185,263
Stock-based compensation	19,854	'	19,854	'	'	'
Balance at Jun. 30, 2014	($6,713,663)	$5,305	$14,548,807	$36,669	'	($21,313,444)
Balance, shares at Jun. 30, 2014	5,304,072	5,304,072	'	'	'	'

STATEMENTS_OF_CHANGES_IN_STOCK1

STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) (USD $)

0 Months Ended

1 Months Ended

Nov. 19, 2012

Jul. 29, 2011

31-May-11

Apr. 29, 2011

Mar. 31, 2011

Jan. 31, 2011

Oct. 07, 2008

Sep. 27, 2008

Dec. 14, 2006

Oct. 05, 2006

Aug. 15, 2006

Jun. 30, 2006

Jun. 16, 2006

Mar. 31, 2006

Jan. 26, 2006

31-May-05

Apr. 05, 2005

Jan. 14, 2005

Nov. 25, 2004

Mar. 16, 2004

Dec. 31, 2010

Jan. 31, 2009

STATEMENTS OF CHANGES IN STOCKHOLDERS? EQUITY (DEFICIT) [Abstract]

Common stock issued, price per share

$6.25

$5.52

$4.31

$3.91

$3.63

$1.47

$3.37

$1.72

$1.76

$6.25

$6.02

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended		153 Months Ended
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
Cash flows from operating activities:	'	'	'
Income (loss) for the period	$4,525,009	($1,920,192)	($20,561,670)
Adjustments to reconcile income (loss) for the period to net cash used in operating activities:	'	'	'
Depreciation	16,610	14,724	208,327
Increase in liability for employee rights upon retirement	'	108	196,506
Stock-based compensation	19,854	12,472	1,635,898
Stock-based interest compensation to convertible notes holders	'	'	1,214,943
Issuance costs allocated to warrants with down-round protection	'	390,928	390,928
Change in the fair value of warrants issued with round down protection	-6,293,705	-68,643	-78,355
Linkage difference on principal of loans from stockholders	-1,315	11,567	199,965
Interest on convertible notes	'	'	78,192
Gain on sale of property and equipment	'	'	-912
Gain from trading marketable securities	'	'	-12,920
Changes in assets and liabilities:	'	'	'
Decrease (increase) in other current assets	-24,756	6,526	-99,408
Increase in accounts payable	118,346	49,577	163,079
Increase (decrease) in other current liabilities	83,862	-19,194	317,505
Net cash used in operating activities	-1,556,095	-1,522,127	-16,347,922
Cash flows from investment activities:	'	'	'
Increase in funds in respect of employee rights upon retirement	'	-42,313	-149,221
Purchase of property and equipment	-47,919	-33,963	-332,291
Proceeds from sale of property and equipment	'	'	4,791
Investment in marketable securities	'	'	-388,732
Proceeds from sale of marketable securities	'	'	406,995
Short-term loan granted to related party, net of repayments	'	'	-14,252
Net cash used in investment activities	-47,919	-76,276	-472,710
Cash flows from financing activities	'	'	'
Credit from banking institutions (repayment)	'	-38,140	-8,671
Proceeds from issuance of convertible notes	'	'	1,144,000
Repayment of convertible notes	'	'	-527,396
Proceeds from issuance of Common Stock, net of issuance expenses	'	'	11,323,559
Dividend to Preferred Stock holders	-185,263	-15,750	-473,511
Proceeds allocated to convertible Preferred Stock, net of issuance expenses	'	3,960,958	3,960,958
Proceeds allocated to warrants with "down-round" protection, net of issuance expenses	'	1,421,983	1,421,983
Proceeds from stockholders loans	'	'	347,742
Net cash provided by (used in) financing activities	-185,263	5,329,051	17,188,664
Effect of exchange rate changes on cash and cash equivalents	-6,898	47,215	221,704
Increase (decrease) in cash and cash equivalents	-1,796,175	3,777,863	589,736
Cash and cash equivalents at beginning of the period	2,385,911	543,411	'
Cash and cash equivalents at end of the period	$589,736	$4,321,274	$589,736

CONSOLIDATED_STATEMENTS_OF_CAS1

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) (Conversion of Preferred Stock into Common Stock [Member], USD $)	3 Months Ended
	Mar. 31, 2014
Conversion of Preferred Stock into Common Stock [Member]	'
Conversion of Stock [Line Items]	'
Amount of stock converted	$5,888
Number of shares converted	10.01
Number of shares issued upon conversion	1,725

GENERAL

GENERAL	6 Months Ended
	Jun. 30, 2014
GENERAL [Abstract]	'
GENERAL	'
	NOTE 1	-	GENERAL

		A.	Integrity Applications, Inc. (the "Company") was incorporated on May 18, 2010 under the laws of the State of Delaware. On July 15, 2010, Integrity Acquisition Corp. Ltd. (hereinafter: "Integrity Acquisition"), a wholly owned Israeli subsidiary of the Company, which was established on May 23, 2010, completed a merger with A.D. Integrity Applications Ltd. (hereinafter: "Integrity Israel"), an Israeli corporation that was previously held by the stockholders of the Company. Pursuant to the merger, all equity holders of Integrity Israel received the same proportional ownership in the Company as they had in Integrity Israel prior to the merger. Following the merger, Integrity Israel remained a wholly-owned subsidiary of the Company. As the merger transaction constituted a structural reorganization, the merger has been accounted for at historical cost in a manner similar to a pooling of interests. On this basis, stockholders' equity has been retroactively restated such that each ordinary share of Integrity Israel is reflected in stockholders' equity as a share of Common Stock of the Company as of the date of the issuance thereof by Integrity Israel. In addition, the historical financial statements of the Company for all dates prior to May 18, 2010 have been retroactively restated to reflect the activities of Integrity Israel.

	Integrity Israel was incorporated in 2001 and commenced its operations in 2002. Integrity Israel, a medical device company, focuses on the design, development and commercialization of non-invasive glucose monitoring devices for home use by persons suffering with diabetes. Since its inception, Integrity Israel has devoted substantially all of its efforts to business planning, research and development and raising capital, and has not yet generated any revenues. Accordingly, Integrity Israel (and therefore the Company) is considered to be in the development stage as defined in Financial Accounting Standards Board ("FASB") Accounting Standards Codification (ASC) Topic 915, "Development Stage Entities".

		B.	Going concern uncertainty

	Since its incorporation, the Company did not conduct any material operations other than those carried out by Integrity Israel. The development and commercialization of Integrity Israel's product is expected to require substantial expenditures. Integrity Israel and the Company (collectively, the "Group") have not yet generated any revenues from operations, and therefore they are dependent upon external sources for financing their operations. Since inception, the Group has incurred accumulated losses of $20,561,670, stockholder's deficit of $6,713,663 and cumulative negative operating cash flow of $16,347,922. These factors raise substantial doubt about the Group's ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. During 2011, the Company raised funds via the issuance of Common Stock in a total amount of approximately $2.4 million (net of related expenses). During 2012, the Company raised a total amount of approximately $1.0 million (net of related expenses) from the issuance of Common Stock. During 2013, the Company raised funds in an approximate amount of $5.3 million (net of related expenses) from the issuance of units (the "Units") consisting of shares of the Company's Series A Convertible Preferred Stock (the "Preferred Stock") and detachable warrants to purchase shares of the Company's Common Stock. As more fully described in Note 10.A.2 to the Company's annual report on Form 10-K for the year ended December 31, 2013, the Company will not be permitted to, among other things, incur indebtedness without the written consent of the holders of a majority in stated value of the outstanding Preferred Stock. Until such time as the Group generates sufficient revenue to fund its operations (if ever), the Group plans to finance its operations through the sale of equity or equity-linked securities and/or debt securities and, to the extent available, short term and long term loans. There can be no assurance that the Group will succeed in obtaining the necessary financing to continue its operations.

		C.	Risk factors

	The Group has a limited operating history and faces a number of risks, including uncertainties regarding finalization of the development process, demand and market acceptance of the Group's products, the effects of technological changes, competition and the development of products by competitors. Additionally, other risk factors also exist, such as the ability to manage growth and the effect of planned expansion of operations on the Group's future results. In addition, the Group expects to continue incurring significant operating costs and losses in connection with the development of its products and marketing efforts. The Group has not yet generated any revenues from its operations to fund its activities and therefore the Group is dependent on the receipt of additional funding from its stockholders and investors in order to continue as a going concern (See Note 1B).

		D.	Use of estimates in the preparation of financial statements

	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these condensed consolidated interim financial statements, the most significant estimates and assumptions relate to (i) the fair value estimate of the warrants with down-round protection and (ii) the going concern assumptions.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 2	-	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

		A.	Basis of presentation

	The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements.

	In the opinion of management, the unaudited interim financial statements furnished herein include all adjustments necessary (consisting of normal recurring adjustments) for a fair presentation of the Company's financial position at June 30, 2014 and the results of its operations and cash flow for each of the six and three month periods then ended.

	Interim financial statements are prepared on a basis consistent with the Company's annual financial statements. For a description of the significant accounting policies, other than the additional policies described in paragraph C below, refer to the Company's annual report on Form 10-K for the year ended December 31, 2013. Results of operations for the six and three month periods ended June 30, 2014 are not necessarily indicative of the operating results that may be expected for the year ending December 31, 2014.

	The consolidated balance sheet as of December 31, 2013 was derived from the audited financial statements as of that date but does not include all of the information and notes required by U.S. GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto included in the Company's annual report on Form 10-K for the year ended December 31, 2013.

		B.	Warrants with Down-Round Protection

	The Company has determined its derivative warrant liability to be a Level 3 fair value measurement and has used the binomial pricing model to calculate its fair value. Because the warrants contain a price protection feature (i.e., a feature providing that, upon the issuance of equity or equity linked securities at an effective price per share that is lower than the exercise price of the warrants, the exercise price of the warrants will be adjusted to such lower price), the probability that the exercise price of the warrants would decrease as the stock price decreases was incorporated into the valuation calculations. The key inputs used in the fair value calculations were as follows:

			30-Jun-14
	Dividend yield (%)			-
	Expected volatility (%) (*)			105.14
	Risk free interest rate (%)			1.14
	Expected term of options (years) (**)			3.7
	Common share price (US dollars) (***)			2.31
	Fair value per Warrant with down-round protection (US dollars)			1.249

		(*)	Due to the very low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.

		(**)	Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No. 110.

		(***)	Share Price reflects the fair value per share of the Company's Common Stock as of June 30, 2014 and was based on management's estimate, which considered, among other things, current expectation of management regarding the price of future issuances of equity-linked financial instruments.

		C.	Recently issued accounting pronouncements

		1.	ASC Topic 830, Foreign "Currency Matters"

	Effective January 1, 2014, the Group adopted Accounting Standards Update 2013-5, Foreign Currency Matters (Topic 830): Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity ("ASU 2013-5").

	ASU 2013-5 clarifies among other things that, when a reporting entity (parent) ceases to have a controlling financial interest in a subsidiary or group of assets that is a business (other than a sale of in-substance real estate or conveyance of oil and gas mineral rights) within a foreign entity, the parent is required to apply the guidance in Subtopic 830-30 to release any related cumulative translation adjustment into net income. Accordingly, the cumulative translation adjustment should be released into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided.

	For public companies, the amendments in ASU 2013-5 became effective prospectively for fiscal years (and interim reporting periods within those years) beginning after December 15, 2013. The amendments should be applied prospectively to derecognition events occurring after the effective date. Prior periods should not be adjusted.

	The adoption of the standard did not have a material impact on the Group's consolidated results of operations and financial condition.

		2.	ASC Topic 915, "Development Stage Entities"

	On June 10, 2014, the FASB issued Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements (which includes an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation) (ASU 2014-10). The amendments in ASU 2014-10 remove all incremental financial reporting requirements from U.S. GAAP for development stage entities, including the removal of Topic 915, Development Stage Entities, from the FASB Accounting Standards Codification. In addition, ASU 2014-10 amends the disclosures required in Topic 275, Risks and Uncertainties, to illustrate relevant disclosures about the risks and uncertainties related to current activities of an entity that has not begun planned principal operations. Also, ASU 2014-10, removes an exception provided to development stage entities in Topic 810, Consolidation, for determining whether an entity is a variable interest entity.

	Under current U.S. GAAP, a development stage entity is defined as an entity that devotes substantially all of its efforts to establishing a new business and for which: (a) planned principal operations have not commenced; or (b) planned principal operations have commenced, but have produced no significant revenue. Currently, U.S. GAAP requires that a development stage entity present the same basic financial statements and apply the same recognition and measurement rules as established companies and in addition, present inception-to-date information about income statement line items, cash flows, and equity transactions.

	The amendments related to the elimination of inception-to-date information and the other remaining disclosure requirements of Topic 915 should be applied retrospectively except for the clarification to Topic 275, which shall be applied prospectively. For public business entities, those amendments are effective for annual reporting periods beginning after December 15, 2014, and interim periods therein (fiscal 2015 for the Company). For public business entities, the amendment eliminating the exception to the sufficiency-of-equity-at-risk criterion for development stage entities should be applied retrospectively for annual reporting periods beginning after December 15, 2015, and interim periods therein.

	Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued (public business entities) or made available for issuance (other entities). Upon adoption, entities will no longer present or disclose any information required by Topic 915. The Company has not yet adopted ASU-2014-10.

	Other than the elimination of the inception-to-date information and other disclosure requirements of Topic 915, the adoption of ASU 2014-10 is not expected to have a material impact on the financial position or results of operations of the Company.

INCOME_LOSS_PER_SHARE

INCOME (LOSS) PER SHARE	6 Months Ended
INCOME (LOSS) PER SHARE	Jun. 30, 2014
INCOME (LOSS) PER SHARE [Abstract]	'
INCOME (LOSS) PER SHARE	'
	NOTE 3	-	INCOME (LOSS) PER SHARE

	Basic income (loss) per share is computed by dividing net income (loss) for the period after consideration of the effect of dividend on preferred stock by the weighted average number of shares outstanding during the period.

	The income (loss) and the weighted average number of shares used in computing basic and diluted income (loss) per share for the six and three month periods ended June 30, 2014 and 2013 are as follows:

			US dollars						US dollars
			Six month period						Three month period
			ended June 30,						ended June 30,
			2014			2013			2014			2013
			(unaudited)						(unaudited)
	Income (loss) for the period			4,525,009			(1,920,192	)		5,261,928			(576,597	)
	Dividend on Preferred Stock			(185,263	)		(102,819	)		(92,589	)		(87,069	)
	Income attributable to participating securities (Preferred Stock)			(842,475	)		-			(1,003,097	)		-
	Income (loss) for the period attributable to common stockholders			3,497,271			(2,023,011	)		4,166,242			(663,666	)

			Number of shares						Number of shares
			Six month period						Three month period
			ended June 30,						ended June 30,
			2014			2013			2014			2013

	Number of shares:
	Common shares used in computing Basic income (loss) per share			5,303,529			5,363,302			5,304,072			5,297,693
	Common shares used in computing Diluted income (loss) per share (*)			5,361,570			5,363,302			5,336,019			5,297,693
	Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted loss per share (**)			3,324,535			3,422,551			3,369,743			3,422,551

		(*)	In applying the treasury method, the average market price of Common Stock was based on management estimate (see Note 2B, above).

		(**)	The Company excludes from the calculation of diluted income per share, shares that will be issued upon the exercise of options and warrants with exercise prices, that are greater than the estimated average market value of the Company's Common Stock and shares issuable upon conversion of Preferred Stock because their effect would be anti-dilutive.

	Outstanding shares that will be issued upon conversion or exercise, as applicable, of all convertible Preferred Stock, stock options and warrants, have been excluded from the calculation of the diluted net loss per share for all the reported periods for which net loss was reported because the effect of the common shares issuable as a result of the exercise or conversion of these instruments was anti-dilutive.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)	6 Months Ended
	Jun. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Basis of presentation	'
		A.	Basis of presentation

	The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements.

	In the opinion of management, the unaudited interim financial statements furnished herein include all adjustments necessary (consisting of normal recurring adjustments) for a fair presentation of the Company's financial position at June 30, 2014 and the results of its operations and cash flow for each of the six and three month periods then ended.

	Interim financial statements are prepared on a basis consistent with the Company's annual financial statements. For a description of the significant accounting policies, other than the additional policies described in paragraph C below, refer to the Company's annual report on Form 10-K for the year ended December 31, 2013. Results of operations for the six and three month periods ended June 30, 2014 are not necessarily indicative of the operating results that may be expected for the year ending December 31, 2014.

	The consolidated balance sheet as of December 31, 2013 was derived from the audited financial statements as of that date but does not include all of the information and notes required by U.S. GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto included in the Company's annual report on Form 10-K for the year ended December 31, 2013.
Warrants with Down-Round Protection	'
		B.	Warrants with Down-Round Protection

	The Company has determined its derivative warrant liability to be a Level 3 fair value measurement and has used the binomial pricing model to calculate its fair value. Because the warrants contain a price protection feature (i.e., a feature providing that, upon the issuance of equity or equity linked securities at an effective price per share that is lower than the exercise price of the warrants, the exercise price of the warrants will be adjusted to such lower price), the probability that the exercise price of the warrants would decrease as the stock price decreases was incorporated into the valuation calculations. The key inputs used in the fair value calculations were as follows:

			30-Jun-14
	Dividend yield (%)			-
	Expected volatility (%) (*)			105.14
	Risk free interest rate (%)			1.14
	Expected term of options (years) (**)			3.7
	Common share price (US dollars) (***)			2.31
	Fair value per Warrant with down-round protection (US dollars)			1.249

		(*)	Due to the very low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.

		(**)	Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No. 110.

		(***)	Share Price reflects the fair value per share of the Company's Common Stock as of June 30, 2014 and was based on management's estimate, which considered, among other things, current expectation of management regarding the price of future issuances of equity-linked financial instruments.
Recently issued accounting pronouncements	'
		C.	Recently issued accounting pronouncements

		1.	ASC Topic 830, Foreign "Currency Matters"

	Effective January 1, 2014, the Group adopted Accounting Standards Update 2013-5, Foreign Currency Matters (Topic 830): Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity ("ASU 2013-5").

	ASU 2013-5 clarifies among other things that, when a reporting entity (parent) ceases to have a controlling financial interest in a subsidiary or group of assets that is a business (other than a sale of in-substance real estate or conveyance of oil and gas mineral rights) within a foreign entity, the parent is required to apply the guidance in Subtopic 830-30 to release any related cumulative translation adjustment into net income. Accordingly, the cumulative translation adjustment should be released into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided.

	For public companies, the amendments in ASU 2013-5 became effective prospectively for fiscal years (and interim reporting periods within those years) beginning after December 15, 2013. The amendments should be applied prospectively to derecognition events occurring after the effective date. Prior periods should not be adjusted.

	The adoption of the standard did not have a material impact on the Group's consolidated results of operations and financial condition.

		2.	ASC Topic 915, "Development Stage Entities"

	On June 10, 2014, the FASB issued Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements (which includes an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation) (ASU 2014-10). The amendments in ASU 2014-10 remove all incremental financial reporting requirements from U.S. GAAP for development stage entities, including the removal of Topic 915, Development Stage Entities, from the FASB Accounting Standards Codification. In addition, ASU 2014-10 amends the disclosures required in Topic 275, Risks and Uncertainties, to illustrate relevant disclosures about the risks and uncertainties related to current activities of an entity that has not begun planned principal operations. Also, ASU 2014-10, removes an exception provided to development stage entities in Topic 810, Consolidation, for determining whether an entity is a variable interest entity.

	Under current U.S. GAAP, a development stage entity is defined as an entity that devotes substantially all of its efforts to establishing a new business and for which: (a) planned principal operations have not commenced; or (b) planned principal operations have commenced, but have produced no significant revenue. Currently, U.S. GAAP requires that a development stage entity present the same basic financial statements and apply the same recognition and measurement rules as established companies and in addition, present inception-to-date information about income statement line items, cash flows, and equity transactions.

	The amendments related to the elimination of inception-to-date information and the other remaining disclosure requirements of Topic 915 should be applied retrospectively except for the clarification to Topic 275, which shall be applied prospectively. For public business entities, those amendments are effective for annual reporting periods beginning after December 15, 2014, and interim periods therein (fiscal 2015 for the Company). For public business entities, the amendment eliminating the exception to the sufficiency-of-equity-at-risk criterion for development stage entities should be applied retrospectively for annual reporting periods beginning after December 15, 2015, and interim periods therein.

	Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued (public business entities) or made available for issuance (other entities). Upon adoption, entities will no longer present or disclose any information required by Topic 915. The Company has not yet adopted ASU-2014-10.

	Other than the elimination of the inception-to-date information and other disclosure requirements of Topic 915, the adoption of ASU 2014-10 is not expected to have a material impact on the financial position or results of operations of the Company.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	Jun. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Schedule of Fair Value Assumptions Used	'
	The key inputs used in the fair value calculations were as follows:

			30-Jun-14
	Dividend yield (%)			-
	Expected volatility (%) (*)			105.14
	Risk free interest rate (%)			1.14
	Expected term of options (years) (**)			3.7
	Common share price (US dollars) (***)			2.31
	Fair value per Warrant with down-round protection (US dollars)			1.249

		(*)	Due to the very low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.

		(**)	Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No. 110.

		(***)	Share Price reflects the fair value per share of the Company's Common Stock as of June 30, 2014 and was based on management's estimate, which considered, among other things, current expectation of management regarding the price of future issuances of equity-linked financial instruments.

INCOME_LOSS_PER_SHARE_Tables

INCOME (LOSS) PER SHARE (Tables)	6 Months Ended
INCOME (LOSS) PER SHARE (Tables)	Jun. 30, 2014
INCOME (LOSS) PER SHARE [Abstract]	'
Schedule of Loss and Weighted Average Number of Shares	'
	The income (loss) and the weighted average number of shares used in computing basic and diluted income (loss) per share for the six and three month periods ended June 30, 2014 and 2013 are as follows:

			US dollars						US dollars
			Six month period						Three month period
			ended June 30,						ended June 30,
			2014			2013			2014			2013
			(unaudited)						(unaudited)
	Income (loss) for the period			4,525,009			(1,920,192	)		5,261,928			(576,597	)
	Dividend on Preferred Stock			(185,263	)		(102,819	)		(92,589	)		(87,069	)
	Income attributable to participating securities (Preferred Stock)			(842,475	)		-			(1,003,097	)		-
	Income (loss) for the period attributable to common stockholders			3,497,271			(2,023,011	)		4,166,242			(663,666	)

			Number of shares						Number of shares
			Six month period						Three month period
			ended June 30,						ended June 30,
			2014			2013			2014			2013

	Number of shares:
	Common shares used in computing Basic income (loss) per share			5,303,529			5,363,302			5,304,072			5,297,693
	Common shares used in computing Diluted income (loss) per share (*)			5,361,570			5,363,302			5,336,019			5,297,693
	Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted loss per share (**)			3,324,535			3,422,551			3,369,743			3,422,551

		(*)	In applying the treasury method, the average market price of Common Stock was based on management estimate (see Note 2B, above).

		(**)	The Company excludes from the calculation of diluted income per share, shares that will be issued upon the exercise of options and warrants with exercise prices, that are greater than the estimated average market value of the Company's Common Stock and shares issuable upon conversion of Preferred Stock because their effect would be anti-dilutive.
Schedule of Loss and the Weighted Average Number of Shares Used In Computing Basic and Diluted Loss Per Share	'
			Number of shares						Number of shares
			Six month period						Three month period
			ended June 30,						ended June 30,
			2014			2013			2014			2013

	Number of shares:
	Common shares used in computing Basic income (loss) per share			5,303,529			5,363,302			5,304,072			5,297,693
	Common shares used in computing Diluted income (loss) per share (*)			5,361,570			5,363,302			5,336,019			5,297,693
	Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted loss per share (**)			3,324,535			3,422,551			3,369,743			3,422,551

		(*)	In applying the treasury method, the average market price of Common Stock was based on management estimate (see Note 2B, above).

		(**)	The Company excludes from the calculation of diluted income per share, shares that will be issued upon the exercise of options and warrants with exercise prices, that are greater than the estimated average market value of the Company's Common Stock and shares issuable upon conversion of Preferred Stock because their effect would be anti-dilutive.

GENERAL_Details

GENERAL (Details) (USD $)

6 Months Ended

12 Months Ended

153 Months Ended

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Jun. 30, 2014

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Dec. 31, 2007

Dec. 31, 2006

Dec. 31, 2005

Dec. 31, 2004

Dec. 31, 2003

Dec. 31, 2002

Sep. 29, 2001

GENERAL [Abstract]

Deficit accumulated during the development stage

($21,313,444)

($25,653,190)

($21,313,444)

Stockholders' deficit

-6,713,663

-11,063,118

-503,069

968,239

-6,713,663

598,139

-775,742

49,750

542,217

1,776,235

-270,063

-487,627

-388,181

-22,856

Cumulative operating cash flow

-1,556,095

-1,522,127

-16,347,922

Proceeds from issuance of Common Stock, net of issuance expenses

1,000,000

2,400,000

11,323,559

Proceeds from convertible preferred stock and warrants

$5,300,000

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	6 Months Ended
	Jun. 30, 2014
Common Stock [Member]	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'
Share price	$2.31	[1]
Warrant [Member]	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'
Dividend yield	'
Expected volatility	105.14%	[2]
Risk free interest rate	1.14%
Expected term of options	'3 years 8 months 12 days	[3]
Fair value per Warrant with down-round protection	$1.25

[1]	Share Price reflects the fair value per share of the Company's Common Stock as of June 30, 2014 and was based on management's estimate, which considered, among other things, current expectation of management regarding the price of future issuances of equity-linked financial instruments.
[2]	Due to the very low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.
[3]	Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No. 110.

INCOME_LOSS_PER_SHARE_Details

INCOME (LOSS) PER SHARE (Details) (USD $)

3 Months Ended

6 Months Ended

12 Months Ended

15 Months Ended

153 Months Ended

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Dec. 31, 2007

Dec. 31, 2006

Dec. 31, 2005

Dec. 31, 2004

Dec. 31, 2003

Dec. 31, 2002

Jun. 30, 2014

INCOME (LOSS) PER SHARE [Abstract]

Income (loss) for the period

$5,261,928

($576,597)

$4,525,009

($1,920,192)

($9,796,853)

($2,772,307)

($2,364,339)

($2,788,446)

($1,202,296)

($1,528,981)

($1,593,205)

($1,282,842)

($1,055,594)

($288,233)

($350,290)

($63,293)

($20,561,670)

Dividend on Preferred Stock

-92,589

-87,069

-185,263

-102,819

Income attributable to participating securities (Preferred Stock)

-1,003,097

-842,475

Income (loss) for the period attributable to common stockholders

$4,166,242

($663,666)

$3,497,271

($2,023,011)

Number of shares:

Common shares used in computing Basic income (loss) per share

5,304,072

5,297,693

5,303,529

5,363,302

Common shares used in computing Diluted income (loss) per share

5,336,019

[1]

5,297,693

[1]

5,361,570

[1]

5,363,302

[1]

Total weighted average number of common shares related to outstanding convertible Preferred Stock, options and warrants excluded from the calculations of diluted loss per share

3,369,743

[2]

3,422,551

[2]

3,324,535

[2]

3,422,551

[2]

[1]

In applying the treasury method, the average market price of Common Stock was based on management estimate (see Note 2B, above).

[2]

The Company excludes from the calculation of diluted income per share, shares that will be issued upon the exercise of options and warrants with exercise prices, that are greater than the estimated average market value of the Company's Common Stock and shares issuable upon conversion of Preferred Stock because their effect would be anti-dilutive.